Jefferies Financial Group Inc. Invests $15.02 Million in Omada Health, Inc. $OMDA

Jefferies Financial Group Inc. purchased a new stake in shares of Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 684,091 shares of the company's stock, valued at approximately $15,016,000. Jefferies Financial Group Inc. owned 1.12% of Omada Health as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Perceptive Advisors LLC acquired a new position in Omada Health during the 2nd quarter worth about $44,402,000. BlackRock Inc. acquired a new stake in shares of Omada Health during the second quarter worth about $48,775,000. Millennium Management LLC boosted its stake in shares of Omada Health by 1,195.0% in the fourth quarter. Millennium Management LLC now owns 2,272,168 shares of the company's stock valued at $35,855,000 after purchasing an additional 2,096,705 shares during the period. SG Americas Securities LLC acquired a new position in shares of Omada Health in the first quarter valued at approximately $10,401,000. Finally, Madryn Asset Management LP acquired a new stake in Omada Health during the 4th quarter worth approximately $9,212,000.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Citizens Jmp boosted their price target on shares of Omada Health from $27.00 to $32.00 and gave the stock a "market outperform" rating in a research note on Friday, August 14th. The Goldman Sachs Group reiterated a "buy" rating on shares of Omada Health in a research note on Friday, May 8th. Barclays boosted their target price on Omada Health from $20.00 to $25.00 and gave the stock an "overweight" rating in a research note on Monday, August 3rd. Robert W. Baird upped their price target on Omada Health from $15.00 to $25.00 and gave the stock a "neutral" rating in a report on Wednesday, August 12th. Finally, Wall Street Zen raised Omada Health from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Eleven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Omada Health presently has an average rating of "Moderate Buy" and an average price target of $26.50.

Omada Health Stock Performance

NASDAQ:OMDA opened at $24.27 on Friday. The stock has a 50-day simple moving average of $22.15 and a 200-day simple moving average of $17.11. The stock has a market cap of $1.49 billion, a P/E ratio of 485.40 and a beta of 1.73. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92.

Omada Health (NASDAQ:OMDA - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.10. The business had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. On average, equities research analysts predict that Omada Health, Inc. will post 0.09 EPS for the current year.

Insider Activity at Omada Health

In related news, CEO Sean P. Duffy sold 25,886 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $22.68, for a total value of $587,094.48. Following the transaction, the chief executive officer directly owned 411,861 shares of the company's stock, valued at $9,341,007.48. This trade represents a 5.91% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Steven L. Cook sold 33,000 shares of the firm's stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $19.89, for a total value of $656,370.00. Following the transaction, the chief financial officer directly owned 133,359 shares in the company, valued at approximately $2,652,510.51. The trade was a 19.84% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 254,726 shares of company stock worth $5,370,496 over the last quarter. 6.38% of the stock is currently owned by insiders.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source